Expertise in
7
conditions

Dr. Eben Rosenthal

General Surgery
Office
1720 2nd Ave S, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
7
conditions
Office
1720 2nd Ave S, 
Birmingham, AL 

Overview

Eben Rosenthal is a General Surgeon in Birmingham, Alabama. Dr. Rosenthal is highly rated in 7 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Cancer, Oral Squamous Cell Carcinoma, Laryngectomy, and Glossectomy.

His clinical research consists of co-authoring 256 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

General Surgery

Licenses

Otolaryngology in AL

Hospital Affiliations

Vanderbilt University Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Office
1720 2nd Ave S, Birmingham, AL 35294
Other Locations
Regional ENT Associates P.C.
206 Babb Dr Apt A, Lebanon, TN 37087

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Pancreas Cancer During Surgical Procedures
A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Pancreas Cancer During Surgical Procedures
Enrollment Status: Recruiting
Publish Date: March 17, 2026
Intervention Type: Biological, Drug, Procedure
Study Drugs: Panitumumab, Panitumumab-IRDye800
Study Phase: Phase 1/Phase 2
Pilot Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
Pilot Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
Enrollment Status: Suspended
Publish Date: December 24, 2025
Intervention Type: Drug, Procedure
Study Drug: 111I-n Panitumumab
Study Phase: Phase 1
Pilot Study of 89Zr Panitumumab in Pancreas Cancer
Pilot Study of 89Zr Panitumumab in Pancreas Cancer
Enrollment Status: Withdrawn
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Zr-89 Panitumumab
Study Phase: Phase 1
Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer
Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device, Drug
Study Drugs: Panitumumab-IRDye800, Zirconium Zr-89 Panitumumab
Study Phase: Phase 1
A Phase II Study Evaluating Panitumumab-IRDye800 vs. Sentinel Node Biopsy and (Selective) Neck Dissection for Metastatic Lymph Node Identification in Patients With Head and Neck Cancer
A Phase II Study Evaluating Panitumumab-IRDye800 vs. Sentinel Node Biopsy and (Selective) Neck Dissection for Metastatic Lymph Node Identification in Patients With Head and Neck Cancer
Enrollment Status: Completed
Publish Date: November 10, 2022
Intervention Type: Drug
Study Phase: Phase 2
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Enrollment Status: Completed
Publish Date: September 24, 2021
Intervention Type: Drug, Device
Study Phase: Phase 1
Open-Label Study Evaluating Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures
Open-Label Study Evaluating Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures
Enrollment Status: Terminated
Publish Date: March 31, 2020
Intervention Type: Procedure, Biological, Drug
Study Phase: Phase 1/Phase 2
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Enrollment Status: Terminated
Publish Date: June 24, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

256 Total Publications

Implementation of a Prospective, Multi-Center Clinical Study of Dynamic Contrast Fluorescence Imaging to Diagnose Necrotizing Soft-Tissue Infection - Challenges and Lessons Learned.
Implementation of a Prospective, Multi-Center Clinical Study of Dynamic Contrast Fluorescence Imaging to Diagnose Necrotizing Soft-Tissue Infection - Challenges and Lessons Learned.
Journal: Proceedings of SPIE--the International Society for Optical Engineering
Published: April 03, 2026
Similar Doctors
Expertise in
24
conditions
Dr. Bradford Woodworth
General Surgery
Expertise in
24
conditions
Dr. Bradford Woodworth
General Surgery

University Of Alabama Health Services Foundation PC

2000 6th Ave S, 
Birmingham, AL 
 (181.9 miles away)
205-801-8000
Languages Spoken:
English
See accepted insurances

Bradford Woodworth is a General Surgeon in Birmingham, Alabama. Dr. Woodworth is highly rated in 24 conditions, according to our data. His top areas of expertise are Cerebrospinal Fluid Leak, Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Septoplasty, and Endoscopy.

Expertise in
47
conditions
Dr. John Christein
General Surgery
Expertise in
47
conditions
Dr. John Christein
General Surgery

Office

3670 Grandview Pkwy Ste 200, 
Birmingham, AL 
 (186.6 miles away)
205-592-5077
Languages Spoken:
English
See accepted insurances

John Christein is a General Surgeon in Birmingham, Alabama. Dr. Christein is highly rated in 47 conditions, according to our data. His top areas of expertise are Ampullary Cancer, Pancreatic Cancer, Pancreatic Pseudocyst, Pancreaticoduodenectomy, and Pancreatectomy.

Expertise in
15
conditions
Dr. Benjamin Pearce
General Surgery
Expertise in
15
conditions
Dr. Benjamin Pearce
General Surgery

University Of Alabama Health Services Foundation PC

2000 6th Ave S, 
Birmingham, AL 
 (181.9 miles away)
205-934-2003
Languages Spoken:
English
See accepted insurances

Benjamin Pearce is a General Surgeon in Birmingham, Alabama. Dr. Pearce is highly rated in 15 conditions, according to our data. His top areas of expertise are Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Peripheral Artery Disease, Carotid Artery Surgery, and Aneurysm Repair.

Frequently Asked Questions about Dr. Eben Rosenthal

How do I make an appointment with Dr. Eben Rosenthal?

You can book an appointment with Dr. Eben Rosenthal by calling their office at 205-934-9713. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eben Rosenthal a top-rated expert for Laryngectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eben Rosenthal is classified as an Elite expert for Laryngectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eben Rosenthal specialize in?

While Dr. Eben Rosenthal is a General Surgery, they have specific expertise in Laryngectomy, Head and Neck Squamous Cell Carcinoma (HNSCC), and Glossectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Eben Rosenthal participate in research or clinical trials?

Yes. Dr. Eben Rosenthal has published 256 articles and abstracts on conditions like Laryngectomy. You can view a list of Dr. Eben Rosenthal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eben Rosenthal accept my insurance?

Dr. Eben Rosenthal accepts most major insurance plans, including Alliant Health and Anthem BCBS. We recommend calling the office directly at 205-934-9713 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile